Medically reviewed by Jurairat J. Molina, MD Dermatitis is a group of skin problems related to genes, environment, and ...

Many natural home remedies for dry scalp and help relieve dryness and itchiness at home. Here are some options worth trying.

Eczema is a common skin condition, but there are many types of eczema out there. Learn how to identify your rash with these ...

There is no cure for atopic dermatitis (eczema), but there are treatments that can help manage this common ... They are not only harsh but can strip away many of the skin's natural oils. These oils ...

Often considered risk-free due to their “natural” label ... When dermatologists suspect allergic contact dermatitis, the first step is to treat the condition with corticosteroid creams.

whereas contact dermatitis results from external factors. Proper diagnosis is important to ensure that individuals receive the appropriate treatment to help clear the skin and manage the condition.

Adam Christman, DVM, MBA spoke with Andrew Rosenberg, DVM, DACVD about how Zenrelia is a JAK inhibitor designed to disrupt cytokine signaling pathways that trigger itch and inflammation related to ...

The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD). Both products now will be available to a significantly larger ...

EFFICACY: In the pivotal studies, ADORING 1 and ADORING 2, up to 46% of patients on VTAMA cream achieved vIGA-AD™ treatment success ... of VTAMA cream in atopic dermatitis for adults and ...

Galderma CEO FLEMMING ØRNSKOV stated: “As just one example of our innovative, science-based pipeline, Nemluvio is an important and effective new treatment option for patients with atopic dermatitis, ...

2,9-11 “As just one example of our innovative, science-based pipeline, Nemluvio is an important and effective new treatment option for patients with atopic dermatitis, where unmet needs remain.

In August 2024, the FDA approved nemolizumab for the treatment of prurigo nodularis in adults. Authorization applications for nemolizumab for atopic dermatitis and prurigo nodularis are under ...